Opicapone Efficacy and Tolerability in Parkinson's Disease Patients Reporting Insufficient Benefit/Failure of Entacapone.

Mov Disord Clin Pract · 2020 · PMC7604656 · PMID 33163567

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

The subgroup entacapone failures were more than 2.3 times more likely to discontinue opicapone than the entacapone switchers subgroup but this failed to reach statistical significance in multivariate analysis.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.